| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56666880a5e2b7703e98a4f9b2d9daf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c46203eb67d2123ff73ce39a13ca139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b51211f859dc188ed044d2f38fe28683 |
| publicationDate |
2004-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1400242-A1 |
| titleOfInvention |
Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
| abstract |
This invention relates to the use of a tocolytic agent ornagents in combination with selective cyclooxygenase-2ninhibitors of Formula (II) or a pharmaceutically-acceptablensalt or derivative thereof for preparing a medicament fornmaintaining circulation through fetal ductus arteriosusnduring treatment or prevention of preterm labor in ansubject in need of such treatment or prevention. |
| priorityDate |
1997-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |